Top of Page
Skip main navigation

The Use of Directed Probiotics in ME/CFS

In this study, we aim to use the probiotic, Floradapt Intensive GI (other name i3.1), to reduce gastrointestinal (GI) inflammation and normalize the GI, to determine whether resetting your microbiome will help your gut health and perhaps your body as well while simultaneously assessing the effectiveness and safety of this intervention based on the severity of illness.

Who can Participate?
INIM Researchers will evaluate the use of probiotics in 100 participants who:
  • Are between 45 to 70 years of age
  • Meet the Institute of Medicine (Canadian Consensus Criteria) case definition for ME/CFS
  • May or may not be diagnosed with irritable bowel syndrome (IBS)

For more information, please email


Return to INIM Research Studies

Return to top of page